NASDAQ · Financial Statements

Anika Therapeutics, Inc. (ANIK) Financial Statements

$21.00 NASDAQ: ANIK Market Cap $281.04M

Anika Therapeutics, Inc. most recently reported annual revenue of $113.0M, net profit of $-11.0M, revenue has compounded at -2.8% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$148.0M$114.0M$121.0M$120.0M$113.0M
Operating Profit$3.0M$4.0M$1.0M$-5.0M$-11.0M
Net Profit$4.0M$-15.0M$-83.0M$-56.0M$-11.0M
EPS$0.28$-1.02$-5.64$-3.83$-0.76
Op Margin1.8%3.2%0.7%-4.3%-9.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$348.0M$349.0M$271.0M$203.0M$190.0M
Total Liabilities$60.0M$64.0M$58.0M$49.0M$47.0M
Cash$94.0M$86.0M$69.0M$56.0M$57.0M
Borrowings$21.0M$31.0M$28.0M$26.0M$26.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$8.0M$4.0M$-2.0M$5.0M$11.0M
Investing Cash Flow$-8.0M$-15.0M$-11.0M$-16.0M$-7.0M
Financing Cash Flow$-8.0M$-5.0M$-6.0M$-13.0M$-11.0M
Net Cash Flow$-1.0M$-8.0M$-13.0M$-16.0M$0
Free Cash Flow$3.0M$-3.0M$-7.0M$-2.0M$4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.27
EV / EBITDA97.88
FCF Yield0.20%
Quick Ratio3.19
Interest Coverage0.00
Return 1Y34.61%
Return 3Y-37.77%
Return 5Y-61.94%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
ANIK Overview ANIK Dividend Run Stock Screener